Skip to main content

GENZYME CORPORATION LLC v. ZYDUS PHARMACEUTICALS USA INC (2019)

United States Court of Appeals, Federal Circuit.

GENZYME CORPORATION, Sanofi-Aventis U.S., LLC, Plaintiffs-Appellees v. ZYDUS PHARMACEUTICALS (USA) INC., Defendant-Appellant

2018-2362

Decided: August 16, 2019

(Newman, Chen, and Hughes, Circuit Judges). Paul Henry Berghoff, McDonnell, Boehnen, Hulbert & Berghoff, LLP, Chicago, IL, argued for plaintiffs-appellees. Also represented by Alison Jameen Baldwin, Nathaniel Paul Chongsiriwatana, Daniel F. Gelwicks, Nicole E. Grimm, James Lee Lovsin, Jeremy E. Noe, Kurt William Rohde; Jeffrey B. Bove, Ratner Prestia, Wilmington, DE. Chad A. Landmon, Axinn Veltrop Harkrider, LLP, Hartford, CT, argued for defendant-appellant. Also represented by David Keeler Ludwig, Edward M. Mathias; Dan-Feng Mei, New York, NY.

JUDGMENT

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.

Per Curiam

Was this helpful?

Thank you. Your response has been sent.

Welcome to FindLaw's Cases & Codes

A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes visit FindLaw's Learn About the Law.

Go to Learn About the Law
GENZYME CORPORATION LLC v. ZYDUS PHARMACEUTICALS USA INC (2019)

Docket No: 2018-2362

Decided: August 16, 2019

Court: United States Court of Appeals, Federal Circuit.

Get a profile on the #1 online legal directory

Harness the power of our directory with your own profile. Select the button below to sign up.

Sign up

Learn About the Law

Get help with your legal needs

FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.

Learn more about the law
Copied to clipboard